RAYLYTIC, established in 2017, is a Germany-based innovator specializing in AI-powered solutions tailored for MedTechs, CROs, Pharma, clinicians, researchers, and registries. The company leverages Big Data and digitalization to transform healthcare through the efficient management of regulatory requirements for clinical studies and trials.
Operating within an emerging synergy of Digital Health, Health Care, Medical Devices, and Pharmaceutical industries, RAYLYTIC is at the forefront of utilizing data to automate healthcare processes, enhancing patient-centered care through advanced medical data management.
The company's latest financial milestone is a €1.80 million convertible note investment secured on 01 March 2023. This capital injection underscores investor confidence in RAYLYTIC's innovation trajectory and potential market impact in the rapidly evolving digital health landscape.